LC
Lux Capital
Venture CapitalActiveVC based in NYC and Menlo Park investing in counter-conventional, early-stage science and tech ventures, with $2.4B AUM across 8 funds.
246
Investments
10
Exits
$4B
AUM
4.1%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Lux Capital.
Investment Thesis & Strategy
Lux Capital invests in early-stage, counter-conventional science and technology ventures, with a focus on fintech. They invest across various stages and have $2.4B AUM across 8 funds.
Investment Activity
Deals per year over the last 7 years
3
20165
20170
20180
20190
20203
20211
2022Portfolio Companies
Selected investments from their portfolio of 246 companies
A
Altos Labs
Biotech · Growth, 2022
E
Eikon Therapeutics
Biotech · Series B, 2021
A
Aurion Biotech
Biotech · Series A, 2021
K
Kyverna Therapeutics
Biotech · Series A, 2021
R
Recursion Pharmaceuticals
Biotech · Series A, 2017
K
Karius
Healthcare · Series B, 2017
N
Nuro
Robotics · Series A, 2017
S
Standard Cognition
AI/ML · Series A, 2017
V
Vividion Therapeutics
Biotech · Series A, 2017
F
Freenome
Biotech · Series B, 2016
D
Desktop Metal
Robotics · Series B, 2016
A
Atomwise
AI/ML · Series A, 2016
Notable Exits
CompanyTypeYearValue / Acquirer
AledadeAcquisition2024—
Aurion BiotechAcquisition2023—
1366 TechnologiesAcquisition2023—
NuviaAcquisition2021$3.5B
Planet LabsIPO2021$2.8B
ShapewaysIPO2021$605M
Desktop MetalIPO2021$2.5B
Wave ComputingAcquisition2020—
KurionAcquisition2016—
Kythera BiopharmaceuticalsAcquisition2014$2.1B
Frequently Asked Questions
Lux Capital focuses on Series A, Series B, Series C+ stage investments.